Navigation Links
Cynvec to Present at New York Biotechnology Association 18th Annual Meeting
Date:4/13/2009

NEW YORK, April 13 /PRNewswire/ -- Cynvec LLC, a privately held biotechnology company focused on developing novel cancer therapies that harness the apoptotic ability of the sindbis viral vector, today announced that Frank Stonebanks, President and Chief Executive Officer, will present at the NYBA 18th Annual Meeting, Bioscience Industry Showcase on Monday, April 20, 2009 at 9:40am. The presentation will be held at the Marriott Marquis Hotel, Belasco Room, in New York City.

About Cynvec LLC

Cynvec, a privately held biotechnology company, is developing proprietary cancer therapies based on the apoptotic sindbis oncolytic viral vector, a novel technology that targets the over expressed laminin receptor on the surface of many solid tumors without affecting normal cells. Under an exclusive worldwide license from the NYU School of Medicine, Cynvec is developing its lead product, CYN 101, to be used as a single agent or in combination with cytotoxics, monoclonal antibodies, chemotherapeutic agents and radiation. CYN 101 is a replication defective, apoptotic RNA vector that has shown tumor eradication and highly significant survival rates in pre- clinical models of ovarian and pancreatic cancer as both a single agent and in combination with licensed chemotherapies. Cynvec is also developing a companion vector that will provide an in vivo, quantitative, real time cancer diagnostic. Cynvec expects to begin Phase I clinical trials of CYN 101 in ovarian cancer in the third quarter of 2009. The sindbis vector has also demonstrated in vivo efficacy delivering a variety of cytokines directly to tumor sites. Additionally, a screening program is underway to identify small molecules that bind to the laminin receptor, which is implicated in Alzheimer's disease, multiple sclerosis and Parkinson's. Further information on Cynvec can be found at www.cynvec.com.


'/>"/>
SOURCE Cynvec LLC
Copyright©2009 PR Newswire.
All rights reserved

Page: 1

Related biology technology :

1. Cynvec LLC(SM) Appoints Former Johnson & Johnson Executive Frank D. Stonebanks as President and Chief Executive Officer
2. Cynvec LLC(SM) to Present at the Rodman & Renshaw 10th Annual Healthcare Conference on November 11, 2008
3. Cynvec LLC(SM) to Present at the Cowen and Company 29th Annual Health Care Conference
4. Cynvec to Present at the BIO National Venture Conference
5. Imagenetix Inc. to Present at Noble Small Cap Financial Conference on August 21, 2007
6. Avicena Group to Present at Noble Financial Conference
7. Vicus Therapeutics to Present at the 234th American Chemical Society National Meeting in Boston, MA
8. Strategic Diagnostics to Present at Two Upcoming Investor Conferences
9. Intellect Neurosciences, Inc. to Present Data on Alzheimers Vaccine at 13th International Congress of Immunology Conference
10. CEL-SCI to Present at the Noble Financial Conference
11. Lexicon Presents Class of Compounds Modulating TPH1, the Target for its LX1031 Investigational Drug for Irritable Bowel Syndrome
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/30/2015)... March 30, 2015 PMG Research, ... to announce the formation of VaxCorps, a network ... specializing in the conduct of vaccine trials in ... clinical sites have successfully conducted over 500 phase ... seasonal and pandemic influenza as well as a ...
(Date:3/30/2015)... SYDNEY , March 30, 2015 US-Australian ... ) and its subsidiary, CanTx, Inc., and Yale University, ... drug, Cantrixil. The data was presented as an oral ... of Yale Medical School to the 62 nd ... in San Francisco, CA. ...
(Date:3/30/2015)... 29, 2015 A two-day workshop on ... and plenary talks by four leading photonics researchers are ... Optoelectronics next month in Prague, Czech Republic. The ... conferences alongside a two-day exhibition. Sponsored by SPIE, ... event will run 13-16 April in the Clarion Congress ...
(Date:3/29/2015)...  Caris Life Sciences® today announced the presentation ... the company,s panomic, comprehensive tumor profiling service, found ... and difficult to treat gynecological cancers may inform ... improve patient outcomes. These studies were presented today ... Gynecologic Oncology (SGO) 2015 Annual Meeting on Women,s ...
Breaking Biology Technology:PMG Research announces formation of VaxCorps with two industry-leading vaccine site networks 2Yale University and Novogen Release Data on Cantrixil Mode of Action 2Yale University and Novogen Release Data on Cantrixil Mode of Action 3Yale University and Novogen Release Data on Cantrixil Mode of Action 4Laser Energy Advances Among Reports Set for SPIE Optics + Optoelectronics 2Laser Energy Advances Among Reports Set for SPIE Optics + Optoelectronics 3Caris Molecular Intelligence Facilitates Comparison of Biomarker Profiles to Inform Targeted Treatment Strategies in Distinct Gynecological Cancers 2Caris Molecular Intelligence Facilitates Comparison of Biomarker Profiles to Inform Targeted Treatment Strategies in Distinct Gynecological Cancers 3Caris Molecular Intelligence Facilitates Comparison of Biomarker Profiles to Inform Targeted Treatment Strategies in Distinct Gynecological Cancers 4
... veteran brings business development and transaction expertise, ... today,announced the appointment of Paul Truex to its ... CEO of Anthera Pharmaceuticals. Previously he,served as President ... $81 million of institutional capital (including $21000000 from ...
... geographic scales ranging from vast climatic regions of the Earth ... of soil nano-particles in a pinch of soil. , ... properties vary from the summit of a hill down to ... less than a quarter inch in diameter, there is a ...
... 30 /Xinhua-PRNewswire-FirstCall/ -- China,Pharma Holdings, Inc. ("China Pharma" ... and markets generic and branded,bio-pharmaceutical products in China, ... its recently announced financing, issuing five million shares ... per share and three-year warrants,to purchase an aggregate ...
Cached Biology Technology:Trius Appoints Paul Truex to Board of Directors 2Sophisticated soil analysis for improved land use 2China Pharma Holdings, Inc. Closes $10 Million Financing 2China Pharma Holdings, Inc. Closes $10 Million Financing 3
(Date:3/23/2015)... Mar. 23, 2015 NXT-ID, Inc. (NASDAQ: NXTD ) ... the growing mobile commerce market, announces its biometric payment technology, ... on CNBC television starting March 30 th . ... in New York markets. ... are excited about our new ad campaign following the recent ...
(Date:3/20/2015)... --Research and Markets ( http://www.researchandmarkets.com/research/rswjb4/hand_geometry ) has announced ... Business Report" report to their offering. This ... Thousands. The report provides separate comprehensive analytics for the US, ... Europe , Asia-Pacific , ... Annual estimates and forecasts are provided for the ...
(Date:3/20/2015)... , Mar. 19, 2015 Research and Markets ... "Iris Biometrics - Global Strategic Business Report" report to ... for Iris Biometrics in US$ Thousands. The report provides separate ... Japan , Europe , ... , and Latin America . ...
Breaking Biology News(10 mins):NXT-ID's Wocket Smart Wallet to Launch New CNBC Regional TV Ad Campaign 2NXT-ID's Wocket Smart Wallet to Launch New CNBC Regional TV Ad Campaign 3Hand Geometry - Global Strategic Business Report 2015: An Essential Security Component for both Government & Enterprise Sector 2Hand Geometry - Global Strategic Business Report 2015: An Essential Security Component for both Government & Enterprise Sector 3Hand Geometry - Global Strategic Business Report 2015: An Essential Security Component for both Government & Enterprise Sector 4Iris Biometrics - Global Strategic Business Report 2015: System & Network Access Control - A Robust Market Opportunity in the Offing 2Iris Biometrics - Global Strategic Business Report 2015: System & Network Access Control - A Robust Market Opportunity in the Offing 3Iris Biometrics - Global Strategic Business Report 2015: System & Network Access Control - A Robust Market Opportunity in the Offing 4Iris Biometrics - Global Strategic Business Report 2015: System & Network Access Control - A Robust Market Opportunity in the Offing 5
... multiple aspects of life on Earth, including extinctions ... to walk on land, sirenians (manatees) in the ... and Edwards Aquifer development as seen through cave ... decomposition, degassing, climate change, tectonics, volcanics, current velocity ...
... 31 March 2009] Researchers at the Swedish medical university Karolinska ... brain,s frontal and parietal parts, to increase the understanding of ... billions of neurons in the brain interact. One of the ... mechanism in the brain,s neuronal network that restricts the number ...
... reason to hate leftovers. A research study appearing in ... Leukocyte Biology ( http://www.jleukbio.org ) sheds light on ... from the United States and The Netherlands show that ... it worse when leftover remnants of bacteria cell walls, ...
Cached Biology News:April 2009 Geology and GSA Today media highlights 2April 2009 Geology and GSA Today media highlights 3April 2009 Geology and GSA Today media highlights 4April 2009 Geology and GSA Today media highlights 5April 2009 Geology and GSA Today media highlights 6April 2009 Geology and GSA Today media highlights 7April 2009 Geology and GSA Today media highlights 8April 2009 Geology and GSA Today media highlights 9April 2009 Geology and GSA Today media highlights 10April 2009 Geology and GSA Today media highlights 11Computer simulations explain the limitations of working memory 2Bad mix of bacterial remnants and genetics leads to arthritis 2
Recognizes the ~115 kDa NMDA receptor NR1 subunit in rat cortex tissue extracts....
... Monoclonal Anti-β-Tubulin IV Recognizes ... C-terminal sequence of β-tubulin isotype ... tubulin isotypes is observed. ascites ... the C-terminal sequence of β-tubulin ...
Porcine Aortic Endothelial Cells (PAOEC) (>500,000 cells)...
Bovine Pulmonary Artery Smooth Muscle Cells (BPASMC) (>500,000 cells)...
Biology Products: